| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $6.3M | — |
| R&D Expense | $86.4M | -7.8% |
| SG&A Expense | $41.7M | -3.8% |
| Operating Income | -$121.8M | +11.1% |
| Income Tax | $0 | — |
| Net Income | -$112.7M | +15.4% |
| EPS (Basic) | -$1.95 | +17.7% |
| EPS (Diluted) | -$1.95 | +17.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $64.3M | -15.3% |
| Short-term Investments | $108.7M | -33.0% |
| Current Assets | $178.8M | -26.8% |
| Total Assets | $213.3M | -27.7% |
| Current Liabilities | $24.7M | +14.9% |
| Total Liabilities | $54.2M | +7.5% |
| Stockholders' Equity | $159.1M | -34.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$78.6M | +13.6% |
| Capital Expenditures | $679K | +17.7% |
| Investing Cash Flow | $66.4M | +306.0% |
| Financing Cash Flow | $567K | -33.4% |
| Free Cash Flow | -$79.3M | +13.4% |